NCT00719758View on ClinicalTrials.gov

Drug-Drug Interaction Study of TRK-100STP

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Healthy
Interventions
DRUG

TRK-100STP (BERASUS LA)

oral

DRUG

AST-120 (Kremezin®)

oral

Trial Locations (1)

108-8642

Tokyo

Sponsors
All Listed Sponsors
collaborator

Toray Industries, Inc

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00719758 - Drug-Drug Interaction Study of TRK-100STP | Biotech Hunter | Biotech Hunter